NSERecord Date2d ago · 29 Oct 2026, 08:11 pm
Record Date
CARE Ratings Limited · CARERATING
✦ AI SummaryDividend
CARE Ratings Limited has announced a record date of November 6, 2026, for the purpose of determining the eligibility of shareholders entitled for the payment of Interim Dividend for Financial Year 2026-27. The company has also declared an Interim Dividend of Rs. 10/- per equity share of face value of Rs. 10/- each. Additionally, the company has appointed Mr. Jatindar Pal Singh Bajaj as an Additional Director (Non-Executive Non-Independent Director) effective October 29, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
CARE Ratings Limited has informed the Exchange that Record date for the purpose of Dividend is 06-Nov-2026.
Attachments (1)
📄pdf
Download →
CARERATINGS_29102026201025_CARE.pdf
View document text
Date: October 29, 2026
SE/2026-27/66
BSE Limited The National Stock Exchange of India Ltd.
Corporate Relation Department Listing Department
Phiroze Jeejeebhoy Towers Exchange Plaza
Dalal Street Bandra Kurla Complex
Mumbai 400 001 Bandra (East)
Scrip Code: 534804 Mumbai 400 051
Scrip Code: CARERATING
Dear Sir/ Madam,
Sub: Outcome of the meeting of the Board of Directors of CARE Ratings Limited (“Company”)
held on October 29, 2026
With regards to the captioned matter and in compliance with Regulation 30 and Para A of Part A of Schedule
III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing
Regulations’’), this is to inform you that the Board of Directors of the Company at their meeting held today
i.e., Thursday, October 29, 2026, have inter alia:
(i) considered and approved the Unaudited Standalone and Consolidated Financial Results (“Unaudited
Financial Results”) for the quarter and half year ended September 30, 2026, along with Limited Review
Report issued by B S R & Co. LLP, the Statutory Auditors of the Company. A copy of the Unaudited Financial
Results together with the Limited Review Report on the said Unaudited Financial Results has been enclosed.
(ii) declared and approved payment of Interim Dividend of Rs. 10/- (Rupees Ten only) per equity share of
face value of Rs. 10/- (Rupees Ten) each for the Financial Year 2026-27.
Pursuant to Regulation 42 of the Listing Regulations, the Company has fixed the record date as Friday,
November 6, 2026, for the purpose of determining the eligibility of shareholders entitled for the payment of
Interim Dividend for Financial Year 2026-27. The said dividend will be paid / dispatched to shareholders
within the stipulated timelines as prescribed under the Companies Act, 2013.
(iii) considered and approved the appointment of Mr. Jatindar Pal Singh Bajaj (DIN:11700874) as an
Additional Director (designated as Non-Executive Non-Independent Director) of the Company, on the
recommendation of the Nomination and Remuneration Committee, effective October 29, 2026.
CARE Ratings Limited
4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East),
Mumbai - 400 022. Phone: +91-22-6754 3456 • Email: care@careedge.in • www.careedge.in
CIN-L67190MH1993PLC071691
Additional details pursuant to Regulation 30 and other relevant provisions of the Listing Regulations are
enclosed as an Annexure A.
The meeting of the Board of Directors of the Company commenced at 12:00 noon and concluded at 6:30
p.m.
The above information is also being made available on the Company’s website i.e. www.careedge.in.
We request you to kindly take the above on record.
Thanking you,
Yours faithfully,
For CARE Ratings Limited
Manoj Kumar CV
Company Secretary & Compliance Officer
Encl: As Above
CARE Ratings Limited
4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East),
Mumbai - 400 022. Phone: +91-22-6754 3456 • Email: care@careedge.in • www.careedge.in
CIN-L67190MH1993PLC071691
Annexure A
Details required under Regulation 30 of the Listing Regulations
Sr. Particulars Details
1 Reason for change viz. Appointment of Mr. Jatindar Pal Singh Bajaj (DIN:11700874) as
appointment, re- an Additional Director (designated as Non-Executive Non-
appointment, resignation, Independent Director) of the Company.
removal, death or otherwise
2 Date of appointment/re- Appointment with effect from October 29, 2026, subject to
appointment/cessation and approval of Shareholders.
term of appointment
3 Brief Profile (in case of Mr. J P S Bajaj joined LIC in 1989 as a Direct Recruit Officer of
appointment) the 17th Batch. He is a Post Graduate in the field of Economics
from Punjab University, Chandigarh. He has diverse, rich
experience in Marketing, IT, PS and has worked in various
capacities in various important assignments.
During his stint in LIC, he has contributed extensively in the area
of Marketing for more than 25 years. Mr. Bajaj was nominated
by LIC on the Board of Punjab National Bank as Shareholder
Director from LIC for the period October 2023 till May 2026.
4 Disclosure of Relationship Mr. J P S Bajaj is not related to any director of the Company.
between Directors (in case of
appointment of Director)
5 Information required Circular Mr. J P S Bajaj is not debarred from holding the office of the
No. LIST/COMP/14/2018-19 Director by virtue of any SEBI order or order of any authority.
and NSE/CML/2018/02 dated
June 20, 2018, issued by
the BSE and NSE,
respectively
CARE Ratings Limited
4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East),
Mumbai - 400 022. Phone: +91-22-6754 3456 • Email: care@careedge.in • www.careedge.in
CIN-L67190MH1993PLC071691
BS R & Co. LLP 14th Floor, Central B Wing and North C Wing
Nesco IT Park 4, Nesco Center
Western Express Highway
Chartered Accountants
Goregaon (East), Mumbai - 400 063, India
Telephone: +91 (22) 6257 1000
Fax: +91 (22) 6257 1010
Limited Review Report on unaudited consolidated financial results of CARE Ratings
Limited for the quarter ended 30 September 2026 and year to date results for the
period from 1 April 2026 to 30 September 2026 pursuant to Regulation 33 of
Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015, as amended
To the Board of Directors of CARE Ratings Limited
1. We have reviewed the accompanying Statement of unaudited consolidated financial results of CARE
Ratings Limited (hereinafter referred to as "the Parent"), and its subsidiaries (the Parent and its
subsidiaries together referred to as "the Group") for the quarter ended 30 September 2026 and year
to date results for the period from 1 April 2026 to 30 September 2026 ("the Statement"), being
submitted by the Parent pursuant to the requirements of Regulation 33 of the Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as
amendecj_ ("Listing Regulations"). •
2. This Statement, which is the responsibility of the Parent's management and approved by the Parent's
Board of Directors, has been prepared in accordance with the recognition and measurement
principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"),
prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally
accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility
is to express a conclusion on the Statement based on our review.
3. We conducted our review of the Statement in accordance with the Standard on Review Engagements
(SRE) 2410 "Review of Interim Financial Information Petformed by the Independent Auditor of the
Entity", issued by the Institute of Chartered Accountants of India. A review of interim financial
information consists of making inquiries, primarily of persons responsible for financial and accounting
matters, and applying analytical and other review procedures. A review is substantially less in scope
than an audit conducted in accordance with Standards on Auditing and consequently does not enable
us to obtain assurance that we would become aware of all significant matters that might be identified
in an audit. Accordingly, we do not express an audit opinion.
We also performed procedures in accordance with the circular issued by the Securities and Exchange
Board of India under Regulation 33(8) of the Listing Regulations, to the extent applicable.
4. The Statement includes the results of the entities mentioned in Annexure I to the Statement.
5. Based on our review conducted and procedures performed as stated in paragraph 3 above and based
on the consideration of the review reports of the other auditors referred to in paragraph 6 below,
nothing has come to our attention that causes us to believe that the accompanying Statement,
prepared in accordance with the recognition and measurement principles laid down in t
[Showing first 8,000 characters — download PDF for full document]